SFS
Sowell Financial Services’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,554
| Closed | -$393K | – | 1050 |
|
|
2025
Q1 | $393K | Buy |
11,554
+900
| +8% | +$30.6K | 0.02% | 659 |
|
|
2024
Q4 | $419K | Buy |
+10,654
| New | +$419K | 0.02% | 428 |
|
|
2021
Q2 | – | Sell |
-715
| Closed | -$77K | – | 976 |
|
|
2021
Q1 | $77K | Buy |
715
+162
| +29% | +$17.4K | ﹤0.01% | 1484 |
|
|
2020
Q4 | $85K | Buy |
553
+61
| +12% | +$9.38K | ﹤0.01% | 1212 |
|
|
2020
Q3 | $41K | Buy |
492
+120
| +32% | +$10K | ﹤0.01% | 1283 |
|
|
2020
Q2 | $27K | Buy |
372
+67
| +22% | +$4.86K | ﹤0.01% | 1359 |
|
|
2020
Q1 | $13K | Buy |
305
+195
| +177% | +$8.31K | ﹤0.01% | 1520 |
|
|
2019
Q4 | $7K | Buy |
110
+60
| +120% | +$3.82K | ﹤0.01% | 1795 |
|
|
2019
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 2049 |
|